Dr. Inhak Choi
Professor
Microbiology and Immunology
Inje University
Korea
Biography
Education and Training 1989-2003 Ph.D. in Medical microbiology College of Medicine, Seoul National University, Seoul, Korea 1987-1989 M.S. in Medical microbiology College of Medicine, Seoul National University, Seoul, Korea 1981-1987 B.S. in Medicine College of Medicine, Inje University, Busan, Korea Professional Experiences 1990-2000. Full-time instructor and Assistant professor, Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Korea. 2001-2008. Associate professor. Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Korea. 2008-present. Professor and Chair of Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Korea. 2009-present. Director, Advanced Research Center for Multiple Myeloma (ARCMM)
Research Interest
Immunology Tumor Immunology Tumors Tumor Microenvironment Co-signaling molecules
Publications
-
Roh J, Jung K, Lee AN, Kim YM, Huh J, Choi I, Park CS. Expression of immune checkpoint molecule vsig4 is correlated with poor prognosis in multiple myeloma. Pathology. 2016 Feb 1;48:S153-4.
-
Lee SM, Park HY, Suh YS, Yoon EH, Kim J, Jang WH, Lee WS, Park SG, Choi IW, Choi I, Kang SW. Inhibition of acute lethal pulmonary inflammation by the IDO–AhR pathway. Proceedings of the National Academy of Sciences. 2017 Jul 3:201615280.
-
Roh J, Jeon Y, Lee AN, Lee SM, Kim Y, Sung CO, Park CJ, Hong JY, Yoon DH, Suh C, Huh J. The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma. Oncotarget. 2017 Jul 22.
